Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Vancouver
SEC filing record 1 source field available
Fiscal year end
31 December
EUPRAXIA PHARMACEUTICALS INC. has filed 126 SEC EDGAR filings since 11 Jul 2013

SEC filing history

Showing 51-75 of 126 matching filings.

Per page
25
Current page
3
6-K File 001-41923

FORM 6-K

Filing date
24 Sep 2025
Reporting date
24 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SUPPL File 333-276586

SUPPL

Filing date
23 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

6-K

Filing date
23 Sep 2025
Reporting date
23 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

FORM 6-K

Filing date
23 Sep 2025
Reporting date
22 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SUPPL File 333-276586

SUPPL

Filing date
22 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

FORM 6-K

Filing date
22 Sep 2025
Reporting date
22 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

6-K

Filing date
19 Sep 2025
Reporting date
19 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

FORM 6-K

Filing date
02 Sep 2025
Reporting date
02 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

6-K

Filing date
13 Aug 2025
Reporting date
12 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

FORM 6-K

Filing date
22 Jul 2025
Reporting date
22 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

FORM 6-K

Filing date
08 Jul 2025
Reporting date
08 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

FORM 6-K

Filing date
03 Jun 2025
Reporting date
02 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

FORM 6-K

Filing date
02 Jun 2025
Reporting date
30 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

FORM 6-K

Filing date
07 May 2025
Reporting date
07 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

6-K

Filing date
06 May 2025
Reporting date
06 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

FORM 6-K

Filing date
05 May 2025
Reporting date
05 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

FORM 6-K

Filing date
24 Apr 2025
Reporting date
24 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

FORM 6-K

Filing date
21 Mar 2025
Reporting date
20 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

FORM 6-K

Filing date
25 Feb 2025
Reporting date
25 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

FORM 6-K

Filing date
18 Feb 2025
Reporting date
18 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

FORM 6-K

Filing date
20 Nov 2024
Reporting date
20 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

FORM 6-K

Filing date
14 Nov 2024
Reporting date
14 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94690

SCHEDULE 13G

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41923

FORM 6-K

Filing date
13 Nov 2024
Reporting date
13 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .